Answers are grounded in this paper and cite their sources.
Intestinal fermentation activity contributes to gut health through the formation of short-chain carboxylic acids (SCCA). Among the SCCA, comparatively little is known about valerate. We determined the occurrence of valerate in a longitudinal, diet-controlled cohort and in vitro in fecal microbiota batch fermentations. Valerate was detected in the feces of 18/19 participants with an occurence of 27%–100%. In vitro, 16/20 fecal microbiota from different donors produced valerate, suggesting a high capacity of the intestinal microbiota for formation. A lower proportion of propionate was linked to higher valerate occurence in the participants. The known valerate producer Coprococcus was detected in the majority of participants of the cohort. Megasphaera occurred less frequently and at lower diversity. Based on analysis of metagenome-assembled genomes, representatives of Coprococcus and Megasphaera possessed the potential for valerate formation. The relative abundance of Coprococcus was positively correlated to valerate levels in vivo. In vitro, valerate formation was faster at the cost of propionate if Megasphaera, or alternatively, Intestinimonas was present. These data suggest that valerate formation as a trait of the intestinal microbiota shared by at least three taxa. Propionate was identified as a possible precursor in vivo and in vitro.
No takes yet. Share an insight, caveat, or question.
Huertas‐Díaz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: